Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Protective Effects of Fushiming Against Microwave Radiation-Induced Retinal Damage: A Network Pharmacology and Experimental Study.

Created on 08 Sep 2026

Authors

Yue Chen, Kai Wang, Sicheng Yang, Jinyi Cao, Jingang Ma, Yi Qiao, Lu Lei, Bin Feng, Shuibing Liu, Zhifu Yang

Published in

Current eye research. Pages 1-11. Sep 08, 2026. Epub Sep 08, 2026.

Abstract

Human health could be at risk from microwave radiation, especially for the eyes because of their unique anatomical and visual characteristics. This study aimed to investigate whether the Fushiming capsule can protect against microwave radiation-induced retinal damage, oxidative stress, and pathological vascular neovascularization.
A network pharmacology approach was adopted to identify the primary components and action targets of Fushiming with potential treatment effects on the retinal diseases. Moreover, we predicted and verified its mechanisms of action.
Network pharmacology analysis identified 43 principal components in Fushiming, and the protein-protein interaction network analysis revealed several key targets, such as VEGFA and VCAM-1. GO enrichment analysis showed that oxidative stress was an important biological process involved in the pathophysiology of the retinal diseases. In vivo and in vitro experiments revealed that Fushiming significantly alleviated microwave radiation-induced retinal pathological damage and improved electroretinogram responses to restore retinal function. Furthermore, Fushiming significantly increased the serum concentration of superoxide dismutase, glutathione peroxidase, and catalase activities, while reducing reactive oxygen species accumulation. Fushiming markedly downregulated the expression of VEGF, VEGFA, eNOS, VEGFR2, and MMP2 proteins in tissue and cellular samples.
The present results indicate that Fushiming can prevent microwave radiation-induced retinal damage by enhancing antioxidant pathways and inhibiting angiogenesis-related processes.

PMID:
42708859
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement